Multidisciplinary Treatment of Advanced Hepatocellular Carcinoma.

Authors :: Yang Z
Abdrakhimov B
Wang S
Xie QF
Zheng SS
Source :: Case reports in gastroenterology [Case Rep Gastroenterol] 2020 Feb 21; Vol. 14 (1), pp. 98-102. Date of Electronic Publication: 2020 Feb 21 (Print Publication: 2020).
Publication Year :: 2020
Abstract: Current strategy for treatment of hepatocellular carcinoma (HCC) based on Barcelona-Clinic Liver Cancer (BCLC) criteria dictates that patients with advanced-stage HCC are to only receive treatment with tyrosine kinase inhibitors. However, they prolong overall survival just by slightly more than 6 months. In this article, we present a patient with HCC diagnosed at an advanced stage who received multidisciplinary treatment consisting of transarterial chemoembolization, hepatic resection, pulmonary resection, radiofrequency ablation, tyrosine kinase inhibitors, and radiotherapy, and has survived for more than 2 years since diagnosis and counting.<br />Competing Interests: The authors have no conflicts of interest to declare.<br /> (Copyright © 2020 by S. Karger AG, Basel.)